HEPATIC FIBROSIS, MEASURED BY FIBROSCANIN A GROUP OF PATIENTS WITH OBESITY
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2012, Vol 19, Issue 2
Abstract
Introduction. Hepatic steatosis is a reversible condition caused by accumulation of triglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progress to advanced liver disease: fibrosis, cirrhosis, liver failure, cancer, and finally can lead to death; therefore NAFLD contributes significantly to morbidity and mortality of hepatic cause. Materials and methods: The study was conducted on a group of 88 patients with Body Mass Index (BMI) ≥ 30kg/m², they were excluded patients with known diabetes. Results, Discussion: The statistical analysis showed that in more than half of subjects elastometry values were higher than those considered normal, obesity is a risk factor for NAFLD that progresses in hepatic fibrosis. Conclusions: Liver fibrosis is present in high percentage in patients with obesity (52% of subjects) and it was positively correlated with age, arterial stiffness and fasting glucose.
Authors and Affiliations
Raluca Costina Dina, Maria Mota, Iulia Vladu, Ciprian Dina
Keywords
Related Articles
- EP ID EP94059
- DOI 10.2478/v10255-012-0016-2
- Views 110
- Downloads 0
NC Paulescu’s “Traite de Physiologie Medicale”
THE RELATIONSHIP BETWEEN sE-Selectin CONCENTRATIONS, MICROALBUMINURIA AND INSULIN-SENSITIVITY IN TYPE 2 DIABETES PATIENTS
The aim of the study was to examine the effects of poor metabolic control on vascular endothelium, expressed by increased soluble E-selectin concentration, microalbuminuria and their relationship with insulin sensitivity...
CARDIOVASCULAR RISK CALCULATED ON A GROUP OF PATIENTS WITH TYPE 1 DM DIAGNOSED AT LEAST 10 YEARS AGO
Diabetic nephropathy is the most common worldwide cause of renal chronic disease in terminal stage requiring a renal substitution therapy. Microalbuminuria is an independent risk factor for developing diabetic renal dise...
SLEEPING WITH THE ENEMY
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia And Metabolic Syndrome
Introduction and Objective: The aim of this study was to evaluate the relationship between lower urinary tract symptoms (LUTS), benign prostatic hyperplasia, and metabolic syndrome. Methods: 381 patients, over 45 years,...